Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action

Journal of the American Podiatric Medical Association
Mahmoud A Ghannoum

Abstract

Azole antifungal agents (eg, fluconazole and itraconazole) have been widely used to treat superficial fungal infections caused by dermatophytes and, unlike the allylamines (such as terbinafine and naftifine), have been associated with resistance development. Although many published manuscripts describe resistance to azoles among yeast and molds, reports describing resistance of dermatophytes are starting to appear. In this review, I discuss the mode of action of azole antifungals and mechanisms underlying their resistance compared with the allylamine class of compounds. Data from published and original studies were compared and summarized, and their clinical implications are discussed. In contrast to the cidal allylamines, static drugs such as azoles permit the occurrence of mutations in enzymes involved in ergosterol biosynthesis, and the ergosterol precursors accumulating as a consequence of azole action are not toxic. Azole antifungals, unlike allylamines, potentiate resistance development in dermatophytes.

References

Mar 1, 1993·The Journal of Antimicrobial Chemotherapy·T MazzeiP Periti
Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·H Vanden BosscheO Ronin
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·M A GhannoumA Casadevall
Jan 9, 1998·Infectious Disease Clinics of North America·A Espinel-Ingroff
Jan 9, 1999·Clinical Microbiology Reviews·D J SheehanC M Sibley
Jun 15, 1999·Journal of the American Academy of Dermatology·J L Lesher
Dec 22, 1999·Journal of the American Academy of Dermatology·B E Elewski
Jun 19, 2002·Molecular Microbiology·Alex A Neyfakh
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Pranab K MukherjeeMahmoud A Ghannoum
Dec 6, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Aditya K Gupta, Yatika Kohli
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·Colin S OsborneNeil S Ryder
Jun 28, 2006·Antimicrobial Agents and Chemotherapy·E M F RochaD S Perlin
Jan 18, 2008·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson
May 15, 2008·Mycopathologia·Nilce M Martinez-RossiAntonio Rossi
Nov 16, 2011·Future Microbiology·David W Denning, David S Perlin
Nov 22, 2012·Obstetrics and Gynecology·Dror MarchaimJack D Sobel
Dec 13, 2012·Annals of the New York Academy of Sciences·Sarah P Georgiadou, Dimitrios P Kontoyiannis
Feb 16, 2013·Current Opinion in Pulmonary Medicine·Gemma E Hayes, David W Denning
Mar 6, 2013·Antimicrobial Agents and Chemotherapy·Yoshiyuki TatsumiYayoi Nishiyama
May 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan W M van der LindenPaul E Verweij
Jul 3, 2013·Antimicrobial Agents and Chemotherapy·M GhannoumB Hardas
Mar 13, 2014·Antimicrobial Agents and Chemotherapy·Emilia GhelardiFederico Mailland
Jun 6, 2014·PLoS Pathogens·Mahmoud Ghannoum, Nancy Isham
Aug 6, 2014·Antimicrobial Agents and Chemotherapy·S M D K Ganga Senarathna, Kevin T Batty

❮ Previous
Next ❯

Citations

Feb 9, 2017·Frontiers in Microbiology·Liliana ScorzoniAna M Fusco-Almeida
Jul 13, 2017·Mycoses·J Stephen GuffeyWilson Roegge
Mar 14, 2018·Antimicrobial Agents and Chemotherapy·Shivaprakash M RudramurthyArunaloke Chakrabarti
Oct 12, 2018·Mycoses·Songchao YinPeiying Feng
May 21, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·D M L Saunte, R J Hay
Jul 23, 2019·Medical Mycology·Hellen Aparecida Silva PonteFillipe de Oliveira Pereira
Sep 8, 2018·Journal of Fungi·Chioma I AnekeClaudia Cafarchia
Jan 4, 2020·Indian Journal of Dermatology·Fatma Gülru ErdoganGül Aslıhan Çakır Akay
Apr 4, 2021·Antibiotics·Chioma Inyang AnekeClaudia Cafarchia
May 21, 2021·Critical Reviews in Analytical Chemistry·Douglas Dos Santos PortoClésio Soldateli Paim
Jun 17, 2021·The Journal of Dermatological Treatment·Aditya K Gupta, Maanasa Venkataraman
Jul 6, 2021·Indian Journal of Dermatology, Venereology and Leprology·Shyam B VermaResham Vasani
Jun 12, 2021·Clinical and Experimental Dermatology·Chandrashekar B S, Poojitha D S
Sep 3, 2021·Journal de mycologie médicale·Alessandra KoehlerMaria Lúcia Scroferneker
Sep 28, 2021·Antimicrobial Agents and Chemotherapy·Esmat Mirbzadeh ArdakaniVahid Khalaj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

Journal of the American Podiatric Medical Association
Mahmoud A Ghannoum
Expert Opinion on Drug Delivery
Wei YangRobert O Williams
Journal of the American Academy of Dermatology
A K GuptaN H Shear
Journal of the American Academy of Dermatology
J E Birnbaum
© 2022 Meta ULC. All rights reserved